U.S. flag

An official website of the United States government

GTR Home > Tests > Endometrial and/or Uterine Cancer Panel

Overview

Test order codeHelp: CG05

Test name

Help

Endometrial and/or Uterine Cancer Panel

Purpose of the test

Help

This is a clinical test intended for Help: Predictive, Risk Assessment

Condition

Help

Loading data ......

Click Indication tab for more information.

How to order

Help

Ordering provider must fill up a Family History Form for each patient; this form, along with the Provider Assessment Guide, will assist the provider to determine whether the patient meets the established NCCN guidelines for being tested. If patient qualifies, the provider will fill up the requisition form and collect a sample (preferred method is saliva but we can also accept peripheral blood shipped overnight and buccal swabs). Once the sample is collected, the clinic will place the collected specimen and the forms in a provided biohazard bag. Sample and proper documentation then shipped to our facilities inside of a carrier clinical pak envelope. Once the test is processed, results are available for the provider via HIPPA-compliant web portal.
Order URL Help: http://intelligene-cg.com

Specimen source

Buccal swab
Isolated DNA
Paraffin block
Peripheral (whole) blood
Saliva

Methodology

Help
Molecular Genetics
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina MiSeqDx
  • Illumina MiSeq

Summary of what is tested

Loading data ......

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Test services

Help
  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Custom mutation-specific/Carrier testing

Practice guidelines

  • NICE, 2020
    UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020
  • AHRQ, 2013
    Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.